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Abstract
Background: Wilson disease is an inherited disorder in which excessive amount of
copper accumulates in various tissues of the body. Clinical features related to copper
deposition in the liver may appear in the first and second decades followed by
neurologic and psychiatric thereafter; however, many patients have a combination
of these symptoms.
Case: We report a case of 11 year-old girl, admitted to Wad Medani Pediatric
Teaching Hospital with generalized body swellings for four days. Initial investigations
showed proteinuria and hypoalbuminemia, thought to be due to nephrotic syndrome.
Days later, patient developed jaundice and neuropsychiatric manifestations. A slit
lamb examination confirmed the presence of Kayser–Fleischer ring (KF ring) and
she scored high in the scoring system for the diagnosis of Wilson disease. D-
penicillamine treatment therapy was started and unfortunately the patient’s clinical
condition deteriorated gradually, and eventually went into deep coma and died. Wilson
disease mainly affects the liver, but the initial presentation was completely compatible
with nephrotic syndrome.
Conclusion: Diagnosis of Wilson disease should be suspected in a child presenting
with generalized body swellings even in the absence of clinical evidence of hepatic
and/or neuropsychiatric involvements.
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1. Introduction
Wilson disease is an inherited disorder in which excessive amount of copper accu-
mulates in various tissues of the body [1]. Liver and the basal ganglia of the brain
are the primary affected organs [2]. Kayser-Fleischer ring (KF) is the hallmark of Wilson
disease [3]. The disease affects 1 in every 30,000 individuals worldwide and it can affect
people at any age [1]. Although the presentation of the disease can vary widely, clinical
manifestation due to disturbance of liver function, neuropsychiatric manifestations,
and KF ring are the key features of Wilson disease [3]. Low serum ceruloplasmin in
combination with KF rings is sufficient to make the diagnosis; however the scoring
system proposed by the Working Party at the 8th International Meeting on Wilson’s
Disease, Leipzig 2001 has a good diagnostic accuracy [3]. To the best of our knowledge,
Wilson disease has not been reported in Sudanese children. In this case report, we
report a case of Wilson disease in a child presented with generalized body swellings.
2. Case Presentation
We report a case of 11year-old girl with no prior medical history, admitted to Wad
Medani Pediatric Teaching Hospital, with generalized body swelling for four days.The
swellings started in the face and gradually progressed and became generalized. Two
days later, the patient developed jaundice with dark urine and no change in the stool
color or itching. The patient was a fifth class-primary school student with good academic
performance. Parents are first-degree cousins. No family history of similar condition and
no other siblings have similar condition.
Clinical examination showed that the patient was conscious, oriented to time, place,
and person.Blood pressure was 125/85 mmHg, Pulse 90 bpm, and Respiratory rate 26
c/pm. Despite the clinical evidence of ascites, the spleen and liver were not palpable
(liver span = 10 cm). The speech was normal, recent and remote memories were intact,
and no abnormal behavior. In addition, cranial nerves, sensory systems, reflexes, and
sphincters were intact. Upper and lower limbs bilaterally showed normal power, reflexes,
and tone. Examinations of other systems were unremarkable.
Urine analysis showed albuminuria(+++), albumin creatine ratio of 2mg/mmol(normal
range < 3), uncountable RBCs, and no RBCs cast or granular casts in urine.International
normalization ration = 1.1 (normal range is≤ 1.1). Table 1 presents the result of liver function
tests. Renal function tests and electrolytes were within normal range. Serological tests
for hepatitis B and C viruses and human immunodeficiency virus were negative.Random
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blood glucose was 66 mg/dl and complete blood count showed neutrophil leukocyto-
sis.Importantly, abdominal ultrasound confirmed the presence of moderate to-massive
ascites with enlarged liver with coarse texture and irregular border (cirrhotic changes),
thick-edematous gall bladder, and normal biliary system (Figure 1).
Considering the generalized oedema, hypoalbuminemia, and proteinuria, the patient
was diagnosed initially with nephrotic syndrome and put on prednisolone tablets 5mg
at a dose of 1mg/kg/day (3 tablets every 8 hr), frusemide tablets 40mg twice daily, and
penicillin 2 million units every 6 hr. In addition, amlodipine tablets5 mg once daily was
administered to control her high blood pressure. After a few days, the patient showed a
considerable clinical improvement in terms of reduction in body swelling, improvement
in jaundice, and started to have a clear urine. However, amlodipine was increased to
5 mg twice a day due to persistent high blood pressure. Unfortunately, two days later
following the improvement in her clinical symptoms, she suddenly developed hand
tremors,clumsiness, speech became slurred and dysarthric with drooling of saliva, shuf-
fling gait with tendency to fall, and abnormal behavior (unintentional and purposeless
jumping) was noted. She complained of vague right hypochondriac pain. Blood pressure
was found to be 140/88 mmHg, brain CT was normal (Figure 2) .Importantly, slit lamb
examination by an ophthalmologist showed the presence of KF ring as shown in Figure
3. Due to the unavailability of these investigations in our hospital, we were unable to
perform the 24-hr urine copper and serum ceruloplasmin levels. However, the scoring
systems developed at the 8th International Meeting on Wilson Disease in Leipzig, 2001
may assist in establishing the diagnosis of Wilson disease; a score of 4 is diagnostic
of Wilson disease (Table 2). Serum ceruloplasmin, coombs-negative hemolytic anemia,
KF rings, and neurological symptoms must be applied to establish the scoring system.
Wilson disease scoring system provides a good diagnostic accuracy. Our patient got
a score of 4 (KFring = 2 points and severe neurological symptoms = 2 points) and the
diagnosis of Wilson’s disease was highly likely. Immediately, D-penicillamine tablets
250 mg twice daily was started and zinc acetate syrup was later added as maintenance
therapy.
Days later, the patient’s clinical condition deteriorated gradually, and she became
comatose with Glasgow Coma Scale score of 3. The patient was then put in regimen of
hepatic encephalopathy including dextrose 5% 500ml every 8 hr, cefotaxime injection
at a dose of 20ml/kg/day (900ml every 6hr), metronidazole injection 500ml every 8 hr
and lactulose syrup 5ml twice daily. Unfortunately, she could not recover and died two
days later.
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Diagnostic challenges: 24-hr urine copper and serum ceruloplasmin levels were
not done due to the un-availability of these investigations in our hospital. The scoring
system developed at the 8th International Meeting on Wilson Disease in Leipzig 2001
was possible alternative.
3. Discussion
Wilson disease is an autosomal recessive disorder due to inborn error of metabolism
of copper [3]. High rate of consanguinity increases the chance of passing the genes to
future generation. Although the disease is common in children, the diagnosis is always
difficult [4]. In developing countries, the prevalence has been estimated to be between
6 and 21% of children with chronic liver disease [5].The insidious process of the disease
and complex clinical presentation in association with lack of diagnostic facility may
leave clinician with only possible alternative diagnostic tool which is the use of Wilson
scoring system. The mean age of diagnosis of Wilson disease in Japan was found to
be around 12 years [6]. In this case report, the patient’s age was 11 years. In addition,
our patient presented with generalized body swellings, hypoalbuminemia, proteinuria,
and a possible diagnosis of nephrotic syndrome. Several case reports showed that
the initial presentations of Wilson disease can be similar to nephrotic syndrome [7, 8].
Esezoboret al. reported a diagnosis of Wilson disease in an eight year-old boy from
Nigeria, with an initial presentation of nephrotic syndrome that deteriorated gradually
and developed into jaundice, severe coagulopathy, and prominent extrapyramidal fea-
tures consisting of rigidity, tremors, shuffling gait, slurred speech, and emotional liability
[8]. It was also suggested that any form of liver disease might be present in patients
withWilson disease and the presentation varies from a symptomatic to fulminant hepatic
cirrhosis and hepatic encephalopathy [3]. Our patient developed jaundice, malaise, and
abdominal pain during the course of the disease which raised the suspicion for liver
failure. Liver failure in Wilson disease carries high mortality rate if left untreated [3]
(Table3).
Patients with Wilson disease may first present with neuropsychiatric manifestations.
Tremors, muscle rigidity, dysphagia, dysarthria, ataxia, drooling of saliva, mood liability,
and inappropriate behavior are common [1, 9, 10]. Our patient developed neuropsychi-
atric manifestations very rapidly and subsequently became disabled and bedridden.
In Figure 4 we have shown the sequence of events in days in relation to the clinical
presentation and how her condition deteriorated gradually.
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The diagnosis was made by using the scoring systems developed at the 8th
International Meeting on Wilson Disease. This scoring system has a good diagnostic
accuracy and a high sensitivity and specificity (a score of 4 established the diagno-
sis).Serumceruloplasmin (the major carrier of copper in the blood), total serum copper
(which includes copper incorporated in ceruloplasmin), neurological symptoms, and KF
rings are the main components of the scoring system [3]. A score of 4 can make the
diagnosis of Wilson’s disease.
The commonest ophthalmological finding in patients with Wilson’s disease is KF
ring. It is due to deposition of excess copper on the inner surface of the cornea in
the Descemet membrane. It mainly affects patients with neurological involvement in
Wilson’s disease and is typically not found in every Wilson’s disease patient. It’s color
is usually golden-brown and does not cause any symptoms. Silt lamb examination is
mandatory to confirm its presence. KF ring disappears with treatment over three to five
years in the majority of cases [ 11–13].
Pharmacological management including D-penicillamine, trientine, tetrathiomolyb-
date, and zink are the main stays of treatment [3, 14]. D-penicillamine, the commonly
used drug, increases the urinary excretion of copper. The maintenance dose in pediatric
is 20 mg/kg/day given in two or three divided doses [15]. Zink salts are usually added
to reduce copper absorption and is administered in a dose of 150 mg /day in three
doses, 30 min before meals [3, 13]. Despite all these therapies, liver transplantation is
the treatment of choice for acute liver failure or decompensated liver cirrhosis due to
Wilson’s disease [16].
4. Conclusion
The diagnosis of Wilson’s disease needs a high rate of clinical suspicion. We con-
clude that generalized body swellings might be the first presenting manifestation of
the disease even in the absence of clinical evidence of hepatic or neuropsychiatric
involvements.
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Figure 1: Abdominal ultrasound showing enlarged liver with cirrhotic changes and moderate-to-massive
ascites.
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Figure 2: Brain CT scan of the patient showing normal basal ganglia (white arrow).
Figure 3: A slit lamb examination showing Kayser–Fleischer ring (red arrow).
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Figure 4: Timeline describing patient’s key date in diagnosis.
TABLE 1: Liver function tests.
Test Day 1 Day 10 Normal values
Serum total protein 5.8 5.0 6.6–8.3 mg/dl
Serum albumin 2.2 1.8 3.5–5.3 mg/dl
Serum globulin 3.6 3.1 2.0–3.5 mg/dl
Serum bilirubin 0.9 0.4 Up to 1.1 mg/dl
Conjugated bilirubin 0.3 0.1 Up to 0.25 mg/dl
Unconjugated bilirubin 0.6 0.3 <0.7 mg/dl
Serum alanine transaminase 55 51 Up to 40 U/L
Serum aspartate transaminase 123 123 Up to 40 U/L
Serum alkaline phosphatase 253 247 Up to 115 U/L
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TABLE 2: Scoring systems developed at the 8th International Meeting on Wilson’s disease in Leipzig 2001.
Typical clinical symptoms and signs

















TABLE 3: Prognostic index in Wilson’s disease.







100–150 151–200 201–300 >300 15.39 µmol/L _
AST (U/L) 100–150 151–300 301–400 >400 123 U/L 1
INR 1.3–1.6 1.7–1.9 2.0–2.4 >2.4 1.1 –
WBC (109/L) 6.8–8.3 8.4–10.3 10.4–15.3 >15.3 15.5 109/L 4
Albumin(g/L) 34–44 25–33 21–24 <21 22 g/L 3
TOTAL SCORE 8
A score >11 is associated with high probability of death without liver transplantation
TOTAL SCORE Diagnosis
4 or more Diagnosis established
3 Diagnosis possible, more tests needed
2 or less Diagnosis very unlikely
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